Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NXTM

NxStage Medical (NXTM) Stock Price, News & Analysis

NxStage Medical logo

About NxStage Medical Stock (NASDAQ:NXTM)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$30.00
$30.00
52-Week Range
N/A
Volume
2.61 million shs
Average Volume
1.51 million shs
Market Capitalization
$2.00 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

Remove Ads
Receive NXTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NxStage Medical and its competitors with MarketBeat's FREE daily newsletter.

NXTM Stock News Headlines

Nextcom Ltd.
Forget 99% of the entire stock market. Trade this one stock instead
Jeff Clark says he joined the top 1% of wealthy Americans by doing something radically simple — ignoring 99% of the stock market and trading just one specific gold stock. He calls it the “One Gold Stock Retirement” strategy. Through bull and bear markets alike, he’s used this same trade to rack up triple-digit gains — often outperforming gold itself. And he's not the only one: over 20,000 everyday investors have tapped into this approach to pursue financial freedom. Whether you’re starting with $100 or $1 million, this monthly trade could help you profit in any market — even during crashes.
Omnicell to Buy Ateb, Expand in Adherence Tools Market
See More Headlines

NXTM Stock Analysis - Frequently Asked Questions

NxStage Medical, Inc. (NASDAQ:NXTM) announced its earnings results on Monday, August, 7th. The medical device company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.00. The company's revenue was up .0% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that NxStage Medical investors own include Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW) and Athabasca Oil (ATH).

Company Calendar

Last Earnings
8/07/2017
Today
4/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:NXTM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$393.94 million
Price / Cash Flow
103.07
Book Value
$3.22 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.00 billion
Optionable
Optionable
Beta
0.25
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NXTM) was last updated on 4/6/2025 by MarketBeat.com Staff
From Our Partners